Turn this role into an interview — a resume and cover letter built around what this employer wants.
Amgen is seeking an experienced Feature Owner to bridge business needs and Agile delivery for an automated report authoring platform within the PDAP portfolio. You will define and refine features, coordinate with product owners, engineers, data teams, and stakeholders, and guide delivery with quality and clear acceptance criteria.
The role emphasizes translating requirements into actionable user stories, driving backlog refinement, and ensuring UAT and release readiness.
How might you defy imagination? At Amgen, our shared mission to serve patients drives all that we do. In this vital role, you will join Amgen's Transformative Digital Capabilities (TDC) organization and support delivery of digital and data capabilities within the PDAP portfolio.
As a Feature Owner for an automated report authoring platform, you will bridge business needs and Agile delivery by owning the definition, refinement, and successful execution of features within a broader product or program roadmap. You will work closely with product owners, business stakeholders, engineers, data teams, and end users to ensure features are clearly defined, prioritized appropriately, and delivered with quality. This role is best suited for an experienced professional who works under general direction, applies knowledge of product and delivery practices to problems of diverse scope, contributes to project milestones, and provides day-to-day guidance within a workgroup.
Doctorate OR Master's degree OR Bachelor's degree and 2 years of relevant experience OR Associate's degree and 6 years of relevant experience OR High school diploma / GED and 8 years of relevant experience
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential. For more information, visit www.amgen.com and follow us on www.twitter.com/amgen